BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 14966583)

  • 21. Reversal of multidrug resistance by small interfering double-stranded RNAs in ovarian cancer cells.
    Zhang T; Guan M; Jin HY; Lu Y
    Gynecol Oncol; 2005 May; 97(2):501-7. PubMed ID: 15863151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biological comparison of ovarian cancer resistant cell lines to cisplatin and Taxol by two different administrations.
    Yan XD; Li M; Yuan Y; Mao N; Pan LY
    Oncol Rep; 2007 May; 17(5):1163-9. PubMed ID: 17390060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of topotecan for extending the platinum-free interval in recurrent ovarian cancer: an in vitro model.
    Horowitz NS; Hua J; Gibb RK; Mutch DG; Herzog TJ
    Gynecol Oncol; 2004 Jul; 94(1):67-73. PubMed ID: 15262121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Establishment of cisplatin-resistant variants of human neuroblastoma cell lines, TGW and GOTO, and their drug cross-resistance profiles.
    Iwasaki I; Sugiyama H; Kanazawa S; Hemmi H
    Cancer Chemother Pharmacol; 2002 Jun; 49(6):438-44. PubMed ID: 12107547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Establishment of a cisplatin-induced human hepatocellular carcinoma drug-resistant cell line and its biological characteristics].
    Yang JX; Tang WX
    Ai Zheng; 2002 Aug; 21(8):872-6. PubMed ID: 12478896
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Schedule-dependent reversion of cisplatin resistance by 5-fluorouracil in a cisplatin-resistant human lung adenocarcinoma cell line A549DDP.
    Zhan M; Liu X
    Chin Med J (Engl); 1999 Apr; 112(4):336-9. PubMed ID: 11593534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Establishment and biological analysis of the EC109/CDDP multidrug-resistant esophageal squamous cell carcinoma cell line.
    Wen J; Zheng B; Hu Y; Zhang X; Yang H; Luo KJ; Zhang X; Li YF; Fu JH
    Oncol Rep; 2009 Jul; 22(1):65-71. PubMed ID: 19513506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Expression and reversion of drug resistance- and apoptosis-related genes of a DDP-resistant lung adenocarcinoma cell line A549DDP].
    Wang J; Liu X; Wu M
    Zhonghua Zhong Liu Za Zhi; 1999 Nov; 21(6):422-6. PubMed ID: 11776616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Up-regulation of human chorionic gonadotropin alpha subunit gene and human mitochondrial cytochrome c oxidase subunit II gene in cis-Diamminedichloroplatinum(II)-resistant human head and neck squamous carcinoma cells].
    Higuchi E
    Hokkaido Igaku Zasshi; 1999 May; 74(3):231-8. PubMed ID: 10422566
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced expression of gamma-glutamylcysteine synthetase and glutathione S-transferase genes in cisplatin-resistant bladder cancer cells with multidrug resistance phenotype.
    Kotoh S; Naito S; Yokomizo A; Kohno K; Kuwano M; Kumazawa J
    J Urol; 1997 Mar; 157(3):1054-8. PubMed ID: 9072542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Induction of multidrug resistance in Tca8113 cells by transient exposure to different chemotherapeutic drugs].
    Zhang P; Wang D; Zheng G
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2003 Feb; 21(1):70-3. PubMed ID: 12674630
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Establishment of the drug resistant cell line of choriocarcinoma and the reversal of drug resistance by transfection of human interleukin 2 gene].
    Cui Z; Xiang Y; Yang X
    Zhonghua Fu Chan Ke Za Zhi; 2001 Sep; 36(9):549-53. PubMed ID: 11769671
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cross-resistance of platinum derivatives in H-1R, a cisplatin-resistant cell line.
    Negoro K; Yamano Y; Nakashima D; Saito K; Nakatani K; Shiiba M; Bukawa H; Yokoe H; Uzawa K; Wada T; Tanzawa H; Fujita S
    Oncol Rep; 2009 Feb; 21(2):443-9. PubMed ID: 19148521
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNAs contribute to the chemoresistance of cisplatin in tongue squamous cell carcinoma lines.
    Yu ZW; Zhong LP; Ji T; Zhang P; Chen WT; Zhang CP
    Oral Oncol; 2010 Apr; 46(4):317-22. PubMed ID: 20219416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Establishment of hepatocellular carcinoma multidrug resistant monoclone cell line HepG2/mdr1.
    Chen YB; Yan ML; Gong JP; Xia RP; Liu LX; Li N; Lu SC; Zhang JG; Zeng DB; Xie JG; Yang JY; Yan LN
    Chin Med J (Engl); 2007 Apr; 120(8):703-7. PubMed ID: 17517188
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CXCR4 enhances cisplatin resistance of human tongue squamous cell carcinoma.
    Zhuang XM; Zhou B
    J Oral Pathol Med; 2019 Feb; 48(2):122-128. PubMed ID: 30554431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Study of bcl-2 antisense oligodeoxynucleotides on reversal of cisplatin resistance in ovarian cancer cell line A2780/DDP].
    Li M; Yu LL; Cai LQ; Wang HB; Wang ZH; Wang ZH
    Zhonghua Fu Chan Ke Za Zhi; 2006 Feb; 41(2):121-5. PubMed ID: 16640863
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of DNA damage in transcriptionally active genes by RT-PCR and assessment of repair of cisplatin-induced damage in the glutathione S-transferase-pi gene in human glioblastoma cells.
    Brandt TY; Ali-Osman F
    Toxicol Appl Pharmacol; 1997 Mar; 143(1):22-9. PubMed ID: 9073588
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of combination of gefitinib and cisplatin on tongue squamous cell carcinoma cell lines.
    Helal HH; Qi CE; Zhao YY; Yao CS; Li de C
    J Cancer Res Ther; 2015; 11(1):37-40. PubMed ID: 25879333
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Synergistic effect of bromocriptine combining tumor necrosis factor-alpha on reversing multidrug resistance in a nude mouse model of liver neoplasm].
    Ding L; Chen XP; Zhang ZW; Wang H; Cao B; Wang ZH; Li CL
    Zhonghua Wai Ke Za Zhi; 2005 Oct; 43(19):1248-53. PubMed ID: 16271222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.